Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells
- PMID: 32462956
- DOI: 10.1080/10715762.2020.1752373
Silencing of long non-coding RNA LINC00520 promotes radiosensitivity of head and neck squamous cell carcinoma cells
Abstract
Aberrant expression of LINC00520 has been identified in head and neck squamous carcinoma (HNSCC). However, its function in the radiosensitivity of HNSCC remain unclear. Herein, we aimed to define the role LINC00520 in the radiosensitivity of HNSCC and identify the underlying mechanism. Tumour tissues and adjacent normal tissue were collected from HNSCC patients. Differentially expressed genes (DEGs) in HNSCC tumour were obtained from the cancer genome atlas (TCGA) database. Interactions between LINC00520 and miR-195, homeobox A10 (HOXA10) and miR-195 were evaluated by dual-luciferase reporter gene assay, RNA Immunoprecipitation (RIP), and RNA pull-down assay. The effects of LINC00520/miR-195/HOXA10 on radiosensitivity of HNSCC were analysed in the evaluation of radiotherapy outcome. Cell proliferation, invasion, migration, and apoptosis of HNSCC cells were accessed via gain- and loss-of-function approaches. Tumour xenograft in nude mice was conducted in order to confirm the results in vivo. LINC00520 was upregulated while miR-195 was downregulated in HNSCC cells and tissues. Silencing LINC00520 or overexpressing miR-195 promoted radiosensitivity and inhibited cell proliferation, invasion, migration, and apoptosis in HNSCC. Moreover, these in vitro findings were reproduced in vivo in human HNSCC xenograft in nude mice. LINC00520/miR-195/HOXA10 is involved in the radiosensitivity mediation, providing potential therapeutic target for HNSCC treatment.
Keywords: Head and neck squamous cell carcinoma; Homeobox A10; LINC00520; microRNA-195; radiosensitivity.
Similar articles
-
LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer.Front Immunol. 2022 Mar 2;13:845418. doi: 10.3389/fimmu.2022.845418. eCollection 2022. Front Immunol. 2022. PMID: 35309319 Free PMC article. Review.
-
Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.J Exp Clin Cancer Res. 2018 Oct 30;37(1):264. doi: 10.1186/s13046-018-0942-9. J Exp Clin Cancer Res. 2018. PMID: 30376862 Free PMC article.
-
Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.Cell Prolif. 2019 Sep;52(5):e12651. doi: 10.1111/cpr.12651. Epub 2019 Jul 11. Cell Prolif. 2019. PMID: 31297902 Free PMC article.
-
Silencing of LINC00461 enhances radiosensitivity of lung adenocarcinoma cells by down-regulating HOXA10 via microRNA-195.J Cell Mol Med. 2020 Mar;24(5):2879-2890. doi: 10.1111/jcmm.14859. Epub 2020 Jan 22. J Cell Mol Med. 2020. PMID: 31967713 Free PMC article.
-
Towards system genetics analysis of head and neck squamous cell carcinoma using the mouse model, cellular platform, and clinical human data.Animal Model Exp Med. 2023 Dec;6(6):537-558. doi: 10.1002/ame2.12367. Epub 2023 Dec 21. Animal Model Exp Med. 2023. PMID: 38129938 Free PMC article. Review.
Cited by
-
LncRNAs as Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis.Front Oncol. 2022 May 25;12:767750. doi: 10.3389/fonc.2022.767750. eCollection 2022. Front Oncol. 2022. PMID: 35692742 Free PMC article.
-
Exploring the enigma: history, present, and future of long non-coding RNAs in cancer.Discov Oncol. 2024 Jun 7;15(1):214. doi: 10.1007/s12672-024-01077-y. Discov Oncol. 2024. PMID: 38847897 Free PMC article. Review.
-
The Mechanism of Long Non-coding RNA in Cancer Radioresistance/Radiosensitivity: A Systematic Review.Front Pharmacol. 2022 May 5;13:879704. doi: 10.3389/fphar.2022.879704. eCollection 2022. Front Pharmacol. 2022. PMID: 35600868 Free PMC article. Review.
-
Current advances in the selection of adjuvant radiotherapy regimens for keloid.Front Med (Lausanne). 2022 Nov 8;9:1043840. doi: 10.3389/fmed.2022.1043840. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36425105 Free PMC article. Review.
-
LINC00520: A Potential Diagnostic and Prognostic Biomarker in Cancer.Front Immunol. 2022 Mar 2;13:845418. doi: 10.3389/fimmu.2022.845418. eCollection 2022. Front Immunol. 2022. PMID: 35309319 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous